Edward Samuel Neiss
Physician at Charter Oak Dr, New Canaan, CT

4696939, Sep 29, 1987

Nov 29, 1985

6/802921

John T. Suh - Greenwich CT
John J. Piwinski - Parsippany NJ
Howard Jones - Ossining NY
Edward S. Neiss - New Canaan CT

USV Pharmaceutical Corporation - Tuckahoe NY

A61K 3141, C07D28514

514361

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

4596791, Jun 24, 1986

Jan 10, 1985

6/690387

John J. Piwinski - Port Chester NY
John T. Suh - Greenwich CT
Paul Menard - Tuckahoe NY
Howard Jones - Ossining NY
Edward S. Neiss - New Canaan CT

USV Pharmaceutical Corp. - Tarrytown NY

H61K 3764, C07K 506

514 19

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

4576941, Mar 18, 1986

Feb 29, 1984

6/584576

John T. Suh - Greenwich CT
John J. Piwinski - Parsippany NJ
Howard Jones - Ossining NY
Edward S. Neiss - New Canaan CT

USV Pharmaceutical Corp. - Tarrytown NY

A61K 3154, C07D41712, C07D41312, C07D40112

514222

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

4666906, May 19, 1987

Jul 19, 1985

6/756530

John J. Piwinski - Parsippany NJ
John T. Suh - Greenwich CT
Paul Menard - Tuckahoe NY
Howard Jones - Holmdel NJ
Edward S. Neiss - New Canaan CT
John R. Regan - Mamaroneck NY

USV Pharmaceutical Corporation - Fort Washington PA

A61K 3154, C07D28522

514222

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

6599937, Jul 29, 2003

Sep 25, 2000

09/669013

Edward Neiss - New Canaan CT
Bernard Loev - Medford NJ

Beacon Laboratories, Inc. - Phoenix MD

A01N 3700

514533

The invention relates to methods of modulating gene expression in a hematopoietic cell or augmenting hematopoiesis in a host, as well as methods of treating, preventing, or ameliorating disorders affecting hematopoiesis level in a host, by administering to the host or the hematopoietic cell an effective amount of a compound of formula (I).

4625034, Nov 25, 1986

Feb 4, 1985

6/697999

Edward S. Neiss - New Canaan CT
Rohit M. Desai - Millwood NY
Raymond D. Youssefyeh - Tarrytown NY

USV Pharmaceutical Corp. - Fort Washington PA

C07D21514, C07D21520

546152

This invention relates to novel lipoxygenase inhibitors possessing anti-inflammatory and anti-allergic activities. The present new compounds are di- and tetra-hydroquinoline or di- and tetra-hydronapthalene derivatives, more particularly, 1,2-, 1,4-, 5,6-, or 7,8-dihydro; 1,2,3,4-tetrahydro-; 5,8-dihydro-; or 5,6,7,8-tetrahydroquinoline or napthalene derivatives of a compound of the formula: ##STR1## and oxides, quaternary ammonium salts and acid salts thereof; wherein A is CH or N; Z is an alkylene chain containing up to 10 carbon atoms in the principal chain and a total of up to 12 carbon atoms and the said alkylene chain may be attached to the phenyl group through an oxygen atom; R is the substituent OR. sub. 6 attached to one of the carbon atoms of Z in which R. sub. 6 is H, lower alkyl or phenyl; X is --O(CHR. sub. 5). sub.

4364940, Dec 21, 1982

Feb 23, 1981

6/237234

Edward S. Neiss - New Canaan CT
Bernard Loev - Scarsdale NY

USV Pharmaceutical Corporation - Tarrytown NY

A61K 3160

424230

A composition for the treatment of acne in the form of a solution, lotion or cream containing from about 1 to 10% by weight of a compound of the formula ##STR1## wherein R is an alkyl having up to 6 carbon atoms or aryl having up to 10 carbon atoms and R. sub. 1 and R. sub. 2 are independently hydrogen, lower alkyl having up to 6 carbon atoms, phenyl, phenyl-lower alkyl, lower alkylphenyl, halogen, halophenyl, trifluoromethyl, trifluoromethylphenyl, lower alkoxy, methylenedioxy, and lower alkoxyphenyl.

6124495, Sep 26, 2000

Mar 11, 1997

8/814366

Edward Neiss - New Canaan CT
Bernard Loev - Medford NJ

Beacon Laboratories, Inc. - Phoenix MD

C07C 6976

560104

This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, modulating gene expression and particularly augmenting expression of a tumor suppressor gene and inducing tolerance to an antigen. The methods of the invention use unsaturated oxyalkylene esters.

4650854, Mar 17, 1987

Jun 6, 1985

6/741936

Edward S. Neiss - New Canaan CT
David Stevenson - Scarsdale NY
Laurence L. Ho - New Rochelle NY
Robert C. Liu - White Plains NY
John T. Suh - Greenwich CT

USV Pharmaceutical Corporation - Tuckahoe NY

C07K 736

530307

New peptides are disclosed which have biological activity of the same type as known calcitonins and which are amide analogs of natural calcitonins.

4804742, Feb 14, 1989

Dec 5, 1986

6/938671

Edward S. Neiss - New Canaan CT
David Stevenson - Scarsdale NY
Laurence L. Ho - New Rochelle NY
Robert C. Liu - White Plains NY
John T. Suh - Greenwich CT

Rorer Pharmaceutical Corporation - Fort Washington PA

C07C10352

530307

New peptides are disclosed which have biological activity of the same type as known calcitonins and which are amide analogs of natural calcitonins.